Stanford researchers have formulated a statistical model to determine the risk of breast cancer recurrence with unprecedented accuracy in women 5 – 20 years after initial diagnosis.
Stanford inventors have developed a rechargeable, fluid-based shock absorber material for use in space constrained environments. Foam is the most common form of shock absorption material, but its force exerted is proportional to the degree of displacement.
Stanford researchers in the Goldberg lab have developed a novel method for targeted gene therapy delivery to retinal astrocytes for the treatment of glaucoma and other optic neuropathies.
Stanford researchers in the Goldberg lab have discovered two novel gene therapy targets for the treatment of glaucoma and other optic neuropathies. Glaucoma is the leading cause of irreversible blindness world-wide, affecting millions of adults in the United States alone.
Stanford inventors have developed TrueImage, a machine learning algorithm to assess the quality of patient images sent in for telemedicine appointments.
Researchers at Stanford have designed a new nanophotonic detector to reduce cost, size and power consumption compared to existing thermal infrared (IR) cameras.
Stanford inventors have developed a functionally-graded implant device for the reconstitution of the necrotic area removed after surgical treatment of osteonecrosis of the hip.
To date, there are no treatments to restore neurologic function for the 7 million US patients suffering from chronic ischemic stroke. NR1 therapy provides a novel treatment for this unmet need.
Determining a patient's drug susceptibility is currently a lengthy process requiring hundred to millions of cells. Currently, these cells are labelled, frozen or otherwise manipulated in ways that prevent sequential testing against multiple drugs on the same few cells.
Stanford researchers in the Snyder lab have discovered and developed an innovative immunoglobulin modality for the treatment of insulin resistance and type 2 diabetes.
Stanford researchers have developed a novel catheter technology for sensing embolic delivery and reflux as a strategy to eliminate need for X-ray imaging during angiography.
The Zhenan Bao Research Group at Stanford University developed and manufactured a photo-curable, directly patternable, stretchable, and highly conductive polymer that is ideal for bioelectronic applications, and stretchable electronic devices.
Scientists in the Zhenan Bao Research Group at Stanford developed a process for direct photo-patterning of electronic polymers that improves device density of elastic circuits over 100x.